A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
NKG2D CAR-NK & Ovarian Cancer
- Status
- UNKNOWN
- Phase
- NA
Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
- Status
- RECRUITING
- Phase
- N/A
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
- Status
- RECRUITING
- Phase
- NA
Huaier Granule in Combination With Nilaparil in Therapy Patients With Stage III/IV BRCA Wild-type Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Endocrine Disruptors and Life STILe in Breast Cancer Development
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Adherence and Compliance to ERAS in Gynecological Surgery
- Status
- RECRUITING
- Phase
- N/A
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
- Status
- COMPLETED
- Phase
- NA
EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Assessing the Time Demands of Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance
- Status
- RECRUITING
- Phase
- PHASE2
Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools
- Status
- RECRUITING
- Phase
- N/A
PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
- Status
- COMPLETED
- Phase
- N/A
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)
- Status
- UNKNOWN
- Phase
- N/A